Latest News for: adma

Edit

Statement of Changes in Beneficial Ownership (Form 4) (ADMA Biologics Inc)

Public Technologies 12 Feb 2026
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10. UNITED STATES SECURITIES AND EXCHANGE COMMISSION ... OMB Number ... ADMA BIOLOGICS, INC. [ADMA] 5 ... ADMA Biologics Inc.
Edit

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update

Nasdaq Globe Newswire 12 Jan 2026
FY 2025 Preliminary Unaudited Total Revenue of Approximately $510–511 Million Meets or Exceeds Prior Guidance ... .
Edit

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update (Form 8-K) (ADMA Biologics Inc)

Public Technologies 12 Jan 2026
ADMA) ("ADMA" or the "Company"), a U.S ... Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides its blood ...
Edit

ADMA Biologics Announces Preliminary Full Year 2025 Unaudited Total Revenue and Provides Business Update (ADMA Biologics Inc)

Public Technologies 12 Jan 2026
ADMA) ("ADMA" or the "Company"), a U.S ... Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides its blood ...
Edit

Retail Sales Units Shared with ADMA December 2025 (Ford Otomotiv Sanayi AS)

Public Technologies 06 Jan 2026
) DECEMBER 2025. PC - LCV - MCV sales shared with ADMA. Retail Sales. December 2025. December 2025 YTD. Ford. PC. 3,691. 26,469. LCV ... MCV.
Edit

ADMA Biologics to Present at the J.P. Morgan Healthcare Conference on January 12, 2026

Nasdaq Globe Newswire 05 Jan 2026
ADMA) (“ADMA” or the “Company”), a U.S.-based, end-to-end commercial biopharmaceutical company ...
Edit

Retail Sales Units Shared with ADMA October 2025 (Ford Otomotiv Sanayi AS)

Public Technologies 10 Nov 2025
) OCTOBER 2025. PC - LCV - MCV sales shared with ADMA. Retail Sales. October 2025. October 2025 YTD. Ford. PC. 1,821. 20,878. LCV ... MCV.
Edit

Adma Biologics: Q3 Earnings Snapshot

Image Atlantic City 06 Nov 2025
RAMSEY, N.J. (AP) — RAMSEY, N.J. (AP) — Adma Biologics Inc. (ADMA) on Wednesday reported third-quarter profit of $36.4 million ... .
Edit

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update

Image The Eagle-Tribune 05 Nov 2025
3Q 2025 Total Revenue of $134.2 Million, a 12% YoY Increase ... .
Edit

ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update (Form 8-K) (ADMA Biologics Inc)

Public Technologies 05 Nov 2025
ADMA) ("ADMA" or the "Company"), a U.S ... (ADMA) ... Through its ADMA BioCenters subsidiary, ADMA also operates as an FDA-approved source plasma collector in the U.S., which provides its blood plasma for the manufacture of its products.
Edit

Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) (ADMA Biologics Inc)

Public Technologies 05 Nov 2025
ADMA operates through its wholly owned subsidiaries ADMA BioManufacturing, LLC ("ADMA BioManufacturing") and ADMA BioCenters Georgia Inc.
  • 1

Article Search

tools
×
×
×
×